Yu Yong 4
4 · GENELUX Corp · Filed Apr 17, 2025
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Yu Yong
VP, Clinical Trial Operations
Transactions
- Award
Common Stock
2025-03-14+13,350→ 53,219 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025.